Hadasit Medical Research Services and Development Ltd.
发明人:
SAFADI, Rifaat
申请号：
EP16771544
公开号：
EP3277306A4
申请日:
2016.03.31
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Method for treating, attenuating and/or preventing progression of a liver disorder in a subject, the method including administering a therapeutically effective amount of an agent capable of interfering with, inhibiting and/or preventing neuroligin 4 (NLGn4)-Neurexin 1-beta (Nrx1b) protein-protein interaction； and compositions including the agent.
